Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

How MRNA Stock Performed in 2020

TheMotleyFool

0 0

How MRNA Stock Performed in 2020Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Coming into 2020, Moderna (NASDAQ: MRNA) was a $6.5 billion biotech

https://ycharts.com/companies/MRNA/market_cap">MRNA Market Cap data by https://ycharts.com">YCharts

with the goal of using messenger RNA (mRNA) -- the molecule that tells cells what proteins to make -- to fight and prevent disease. Not much was known about the company's technology or even the diseases its drugs would target, but that changed in 2020 as the company became one of the leaders in the fight against COVID-19.

Source Fool.com

Like: 0

MRNA

Teilen